Action Against 8 top Hospitals for Stent Overcharging in Mumbai

Published On 2017-04-03 04:00 GMT   |   Update On 2017-04-03 04:00 GMT

Mumbai: Maharashtra government told the Legislative Council that since January this year, action has been taken against eight major hospitals in Mumbai, which were found overcharging medical devices like stents.State Food and Drug Administration (FDA) Minister Girish Bapat said the government used provisions under the Legal Metrology Act to crack down on these hospitals.Bapat was speaking...

Login or Register to read the full article

Mumbai: Maharashtra government told the Legislative Council that since January this year, action has been taken against eight major hospitals in Mumbai, which were found overcharging medical devices like stents.


State Food and Drug Administration (FDA) Minister Girish Bapat said the government used provisions under the Legal Metrology Act to crack down on these hospitals.

Bapat was speaking during a debate after a Calling Attention Notice moved by Congress legislator Sanjay Dutt and others. “Eighteen medical devices are included in the list, which have to be sold at the MRP (maximum retail price) only. Action was taken against eight hospitals - Fortis, Breach Candy, Lilavati, Kokilaben Dhirubhai Ambani, Asian Heart Institute, Global, L H Hiranandani and Sir H N Hospital,” Bapat said.

“These hospitals were found to have been charging stents in the range of Rs 1.05 lakh to Rs 1.90 lakh although they had procured the same from importers at Rs 50,000 to Rs 90,000," the minister said.

According to him, the government has filed cases under the Consumer Protection Act, which has provisions up to seven years jail term.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News